A Phase 1 Study to Assess the Safety, Tolerability, Pharmacokinetics, Food Effect, and the Drug-Drug Interaction Potential of Oral ACHN-383 and ACHN-789 in Healthy Subjects and to Assess the Safety, Tolerability, and Pharmacokinetics of Oral ACHN-383 and ACHN-789 in Otherwise Healthy Subjects With Renal Impairment

Trial Profile

A Phase 1 Study to Assess the Safety, Tolerability, Pharmacokinetics, Food Effect, and the Drug-Drug Interaction Potential of Oral ACHN-383 and ACHN-789 in Healthy Subjects and to Assess the Safety, Tolerability, and Pharmacokinetics of Oral ACHN-383 and ACHN-789 in Otherwise Healthy Subjects With Renal Impairment

Recruiting
Phase of Trial: Phase I

Latest Information Update: 03 Aug 2017

At a glance

  • Drugs C-Scape (Primary)
  • Indications Urinary tract infections
  • Focus Adverse reactions
  • Sponsors Achaogen
  • Most Recent Events

    • 03 Aug 2017 According to an Achaogen media release, first patient is dosed in this study.
    • 26 May 2017 New source identified and integrated (NCT03163550).
    • 20 May 2017 Status changed from planning to recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top